pre-seed
Stage
1
Investors
About
KaloCyte develops ErythroMer™, a freeze-dried, bio-inspired artificial red blood cell designed to provide oxygen-carrying capacity in scenarios where stored red blood cells are unavailable, undesirable, or in short supply, particularly for trauma care and transfusion medicine.
Explore KaloCyte's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.